Increased expression of áA-crystallin in human diabetic eye

International Journal of Molecular Medicine

Volumn 28, Issue 4, 2011, Pages 505-511

  Kase, Satoru ^a,c   Ishida, Susumu ^c   Rao, Narsing A ^a,b  

^a DOHENY EYE INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

crystallin; Advanced glycation end products; Apoptosis; Diabetic retinopathy

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA CRYSTALLIN; TOLL LIKE RECEPTOR; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; DIABETIC RETINOPATHY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NICK END LABELING; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VITREOUS BODY; WESTERN BLOTTING; ADULT; AGED; ANIMAL; DIABETES MELLITUS; DRUG EFFECT; FEMALE; GENETICS; IN VITRO STUDY; MALE; METABOLISM; MIDDLE AGED; MOUSE; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; ALPHA-CRYSTALLIN A CHAIN; ALPHA-CRYSTALLIN B CHAIN; ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79960765391     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.708     Document Type: Article

References (30)

1. Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW and Thorpe SR: The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 271: 9982-9986, 1996.
2. Diamanti-Kandarakis E, Piperi C, Patsouris E, Korkolopoulou P, Panidis D, Pawelczyk L, Papavassiliou AG and Duleba AJ: Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem Cell Biol 127: 581-589, 2007. (Pubitemid 46879051)
3. Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB and Vlassara H: Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol 150: 523-531, 1997. (Pubitemid 27073782)
4. Endo M, Yanagisawa K, Tsuchida K, Okamoto T, Matsushita T, Higuchi M, Matsuda A, Takeuchi M, Makita Z and Koike T: Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy. Horm Metab Res 33: 317-322, 2001. (Pubitemid 32579250)
5. Stitt AW, Moore JE, Sharkey JA, Murphy G, Simpson DA, Bucala R, Vlassara H and Archer DB: Advanced glycation end products in vitreous: structural and functional implications for diabetic vitreopathy. Invest Ophthalmol Vis Sci 39: 2517-2523, 1998. (Pubitemid 28558209)
6. Howes KA, Liu Y, Dunaief JL, Milam A, Frederick JM, Marks A and Baehr W: Receptor for advanced glycation end products and age-related macular degeneration. Invest Ophthalmol Vis Sci 45: 3713-3720, 2004. (Pubitemid 39298589)
7. Jakus V and Rietbrock N: Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res 53: 131-142, 2004. (Pubitemid 38525116)
8. Andley UP: Crystallins in the eye: function and pathology. Prog Retin Eye Res 26: 78-98, 2007.
9. Calabrese V, Mancuso C, Sapienza M, Puleo E, Calafato S, Cornelius C, Finocchiaro M, Mangiameli A, Di Mauro M, Stella AM and Castellino P: Oxidative stress and cellular stress response in diabetic nephropathy. Cell Stress Chaperones 12: 299-306, 2007.
10. Oksala NK, Lappalainen J, Laaksonen DE, Khanna S, Kaarniranta K, Sen CK and Atalay M: α-lipoic Acid modulates heat shock factor-1 expression in streptozotocin-induced diabetic rat kidney. Antioxid Redox Signal 9: 497-506, 2007.
11. Voorter CE, Mulders JW, Bloemendal H and de Jong WW: Some aspects of the phosphorylation of α-crystallin A. Eur J Biochem 160: 203-210, 1986.
12. Kantorow M and Piatigorsky J: Phosphorylations of αA- and αB-crystallin. Int J Biol Macromol 22: 307-314, 1998.
13. Andley UP, Song Z, Wawrousek EF, Fleming TP and Bassnett S: Differential protective activity of αA- and αB-crystallin in lens epithelial cells. J Biol Chem 275: 36823-36831, 2000. (Pubitemid 32002093)
14. Mao YW, Liu JP, Xiang H and Li DW: Human αA- and αB-crystallins bind to Bax and Bcl-X(S) to sequester their trans-location during staurosporine-induced apoptosis. Cell Death Differ 11: 512-526, 2004. (Pubitemid 38660137)
15. Liu JP, Schlosser R, Ma WY, Dong Z, Feng H, Liu L, Huang XQ, Liu Y and Li DW: Human αA- and αB-crystallins prevent UVA-induced apoptosis through regulation of PKCα, RAF/MEK/ERK and AKT signaling pathways. Exp Eye Res 79: 393-403, 2004. (Pubitemid 39172124)
16. Kase S, Parikh JG and Rao N: Expression of heat shock protein 27 and α-crystallins in human retinoblastoma after chemoreduction. Br J Ophthalmol 93: 541-544, 2008.
17. Wang YD, Wu JD, Jiang ZL, Wang YB, Wang XH, Liu C and Tong MQ: Comparative proteome analysis of neural retinas from type 2 diabetic rats by two-dimensional electrophoresis. Curr Eye Res 32: 891-901, 2007. (Pubitemid 350034790)
18. Kase S, Yokoi M, Saito W, Furudate N, Ohgami K, Kitamura M, Kitaichi N, Yoshida K, Kase M, Ohno S and Uede T: Increased osteopontin levels in the vitreous of patients with diabetic retinopathy. Ophthalmic Res 39: 143-147, 2007. (Pubitemid 46975979)
19. Rao NA, Saraswathy S, Wu GS, Katselis GS, Wawrousek EF and Bhat S: Elevated retina-specific expression of the small heat shock protein, αA-crystallin, is associated with photoreceptor protection in experimental uveitis. Invest Ophthalmol Vis Sci 49: 1161-1171, 2008.
20. Lin L: RAGE on the Toll Road? (Review). Cell Mol Immunol 3: 351-358, 2006.
21. Pan HZ, Zhang H, Chang D, Li H and Sui H: The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 92: 548-551, 2008. (Pubitemid 351497989)
22. Parikh JG, Saraswathy S and Rao NA: Photoreceptor oxidative damage in sympathetic ophthalmia. Am J Ophthalmol 146: 866-875, 2008.
23. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
24. Zhang J, Wu Y, Jin Y, Ji F, Sinclair SH, Luo Y, Xu G, Lu L, Dai W, Yanoff M, Li W and Xu GT: Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 49: 732-742, 2008.
25. Baynes JW: The role of AGEs in aging: causation or correlation. Exp Gerontol 36: 1527-1537, 2001.
26. den Engelsman J, Bennink EJ, Doerwald L, Onnekink C, Wunderink L, Andley UP, Kato K, de Jong WW and Boelens WC: Mimicking phosphorylation of the small heat-shock protein αB-crystallin recruits the F-box protein FBX4 to nuclear SC35 speckles. Eur J Biochem 271: 4195-4203, 2004. (Pubitemid 39506748)
27. Fukumura D, Kashiwagi S and Jain RK: The role of nitric oxide in tumour progression. Nat Rev Cancer 6: 521-534, 2006. (Pubitemid 43980541)
28. Thomas MC, Forbes JM and Cooper ME: Advanced glycation end products and diabetic nephropathy. Am J Ther 12: 562-572, 2005. (Pubitemid 41689757)
29. Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM and Barile GR: Upregulation of RAGE and its ligands in proliferative retinal disease. Exp Eye Res 82: 807-815, 2006. (Pubitemid 43170881)
30. Yamagishi S, Nakamura K, Matsui T, Ueda S, Fukami K and Okuda S: Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications.Expert Opin Investig Drugs 17: 983-996, 2008.